CAI
Caris Life Sciences, Inc.
31.70$
+0.6%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +12.5% | +5.5% | -12.3% | +20.1% | +15.8% | +41.3% | +9.1% | -203.1% | – | – | – | |
| – | +15.2% | +44.9% | -6.6% | +6.2% | +9.0% | -7.7% | -2.9% | -56.4% | +1.6% | -0.2% | -53.8% | |
| – | +22.7% | +1.6% | -9.6% | +20.5% | +37.4% | -3.8% | -35.6% | +1,190.2% | -33.4% | +22.3% | +275.5% | |
| – | – | – | +46.7% | -302.0% | – | – | -176.1% | – | – | – | – | |
| – | -1.6% | +26.7% | -35.5% | +99.9% | +61.9% | -60.7% | -31.2% | -80.7% | -47.2% | -62.2% | +92.6% | |
| – | -15.5% | +35.5% | -40.5% | +126.7% | +61.1% | -59.0% | -87.5% | +733.1% | – | -75.4% | -130.7% | |
| – | – | – | – | – | – | +170.8% | +100.6% | – | – | – | – | |
| – | – | -58.6% | -29.4% | – | – | -16.5% | -76.7% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | +1,791.0% | -86.1% | |
| – | -44.7% | +64.5% | -70.2% | +427.1% | +108.6% | -121.2% | +130.4% | – | -3.0% | +1,876.8% | +232.0% | |
| – | -71.2% | -115.7% | – | – | – | -109.5% | – | – | – | – | +9,026.2% | |
| – | – | – | – | – | – | – | – | -669.7% | – | – | – |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.